Abstract
The experimental demonstration of the influence of hormones on the genesis of mammary tumors in rodents was begun in 1913 by Lathrop and Loeb, who demonstrated that mammary tumors were more frequent in outbred multiparous mice than in nulliparous mice of the same strain (1). Three years later, Lathrop and Leob reported that ovariectomy of mice at an early age either completely inhibited or greatly delayed the appearance of mammary tumors (2). Since these reports, countless numbers of studies have been reported documenting the exquisite control by the endocrine system of the genesis, development and growth of the rodent mammary tumor. The purpose of this chapter is to provide an assemblage of the currentin vivo mouse and rat mammary tumor models most commonly utilized by the tumor biologist intent on understanding mammary tumor — hormonal regulatory processes; a succinct review of the endocrine responsiveness of these mammary tumor models is provided.
Keywords
- Mammary Gland
- Mammary Tumor
- Mammary Tumorigenesis
- Human Breast Carcinoma Cell Line
- Mammary Tumor Development
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Lathrop, A.E.C., and Loeb, L. The influences of pregnancies on the incidence of cancer in mice. Proc. Soc. Exptl. Biol. Med., 11: 38– 40, 1913.
Lathrop, A.E.C., and Loeb, L. Further investigation on the origin of tumors in mice. III. On the art played by internal secretion in the spontaneous development of tumors. J. Cancer Res., 1: 1– 19, 1916.
Welsch,C.W. Hormones and murine mammary gland tumorigenesis: an historical view.In: B.S. Leung (ed.), Hormonal Regulation of Mammary Tumors, Vol. 1, pp. 1–29. Montreal: Eden Press Inc., 1982.
Welsch, C.W., Adams, C., Lambrecht, L.K., Hassett, C.C., and Brooks, C.L. 17β-Oestradiol and enovid mammary tumorigenesis in C3H/HeJ female mice: counteraction by concurrent 2-bromo-α-ergocryptine. Br. J. Cancer, 35: 322– 328, 1977.
Bonser, G.M. The effect of oestrone administration on the mammary glands of male mice of two strains differing greatly in their susceptibility to spontaneous mammary carcinoma. J. Pathol. Bacteriol., 42: 169– 181, 1936.
Rudali, G., Apiou, F., and Muel, B. Mammary cancer produced in mice with estriol. Europ. J. Cancer, 11: 39–31, 1975.
Shimkin, M.B., and Grady, H.G. Mammary carcinomas in mice following oral administration of stilbestrol. Proc. Soc. Exptl. Biol. Med., 45: 246–248, 1940.
Trentin, J.J. Effect of long-term treatment with high levels of progesterone on the incidence of mammary tumors in ice. Proc. Am. Assoc. Cancer Res., 1: 50, 1954.
Muhlbock, O., and Boot, L.M. Induction of mammary cancer in mice without the mammary tumor agent by isografts of hypophyses. Cancer Res., 19: 402–412, 1959.
Haran-Ghera, N. The role of mammotrophin in mammary tumor induction in mice. Cancer Res., 21: 790–795, 1961.
Lacassagne, A., and Duplan, J.F. Le mecanisme de la cancerisation de la mamelle chez la soures considere d’apres les resultats d’experiences au mojen de la reserpine. C.R. Soc. Biol. (Paris), 249: 810– 812, 1959.
Bruni, J.E., and Montemurro, D.G. Effect of hypothalamic lesions on the genesis of spontaneous mammary gland tumors in the mouse. Cancer Rec., 31: 854–863, 1971.
Boot, L.M., Muhlbock, D., and Ropcke, G. Prolactin and the induction of mammary tumors in mice. Gen. Comp. Endocrinol., 2: 601–603, 1962.
Yanai, R., and Nagasawa, H. Enhancement by pituitary isografts of mammary hyperplastic nodules in adreno-ovariectomized mice. J. Natl. Cancer Inst., 46: 1251–1255, 1971.
Bern, H., and Nandi, S. Recent studies of the hormonal influence in mouse mammary tumorigenesis. Progr. Exptl. Tumor Red., 2: 90–144, 1961.
Welsch, C.W., and Gribler, C. Prophylaxis of spontaneously developing mammary carcinoma in C3H/HeJ female mice by suppression of prolactin. Cancer Res., 33: 2939– 2946, 1973.
Vonderhaar, B.K., and Greco, A.E. Effect of thyroid status on development of spontaneous mammary tumors in primiparous C3H mice. Cancer Res., 42: 4553–4561, 1982.
Kurachi, H., Okamoto, S., and Oka, T. Evidence for the involvement of the submandibular gland epidermal growth factor in mouse mammary tumorigenesis. Proc. Natl. Acad. Sci. (USA), 82: 5940–5943, 1985.
van Nie, R. and Dux, A. Biological and morphological characteristics of mammary tumors in GR mice. J. Natl. Cancer Inst., 46: 885–897, 1971.
van der Valk, M.A. Survival, tumor incidence and gross pathology in 33 mouse strains,In: J. Hilgers and M. Sluyser (eds.), Mammary Tumors in the Mouse, pp. 45–115. Amsterdam: Elsevier/North- Holland Biomedical Press, 1981.
van der Gugten, A.A., Ropcke, G., van Nie, R., and Hilgers, J. Mouse strain (STS/A) resistant to mammary tumor induction by hypophysial isografts. Cancer Res., 45: 3448–3453, 1985.
Medina, D. Preneoplastic lesions in mouse mammary tumorigenesis. Methods Cancer Res., 7: 3– 53, 1973.
DeOme, K.B., Faulkin, L.J., Bern, H.A., and Blair, P.B. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res., 19: 515–520, 1959.
Foulds, L. The histological analysis of mammary tumors in mice. I- VI. J. Natl. Cancer Inst., 17: 701– 801, 1956.
Welsch, C.W. Prolactin and the development and progression of early neoplastic mammary gland lesions. Cancer Res., 38: 4054–4058, 1978.
Yanai, R., and Nagasawa, H. Effect of progesterone and estrogen on DNA synthesis of pregnancy-dependent mammary tumors in GR/A mice. Europ. J. Cancer, 13: 813–816, 1977.
Welsch, C.W., Goodrich-Smith, M., Brown, C.K., and Wilson, M. Inhibition of mammary tumorigenesis in GR mice with 2-bromo-α- ergocryptine. Int. J. Cancer, 24: 92–96, 1979.
Cardiff, R.D. Protoneoplasia: the molecular biology of murine mammary hyperplasia. Adv. Cancer Res., 42: 167–190, 1984.
Faulkin, L.J., Mitchell, D.J., Young, L.J.T., Morris, D.W., Malone, R.W., Cardiff, R.D., and Gardner, M.B. Hyperplastic and neoplastic changes in the mammary glands of feral mice free of endogenous mouse mammary tumor virus provirus. J. Natl. Cancer Inst., 73: 971–982, 1984.
Medina, D. Preneoplastic lesions in murine mammary cancer. Cancer Res., 36: 2589–2595, 1976.
Medina, D. Mammary tumorigenesis in chemical carcinogen-treated mice. II. Dependence on hormone stimulation for tumorigenesis. J. Natl. Cancer Inst., 53: 223–226, 1974.
Medina, D. Mammary tumorigenesis in chemical carcinogen-treated mice. I. Incidence in BALB/c and C57BL mice. J. Natl. Cancer Inst., 53: 213–221, 1974.
Medina, D., and Warner, M.R. Mammary tumorigenesis in chemical carcinogen-treated mice. IV. Induction of mammary ductal hyperplasias. J. Natl. Cancer, Inst., 57: 331–337, 1976.
Haran-Ghera, N. The role of hormones in mammary tumorigenesis. Acta Union Internatl. Contre Le Cancer, 18: 207–210, 1962.
Haran-Ghera, N. Autonomy and dependence of preneoplastic mammary nodules in mice. Br. J. Cancer, 19: 816–823, 1965.
Medina, D., Butel, J.S., Socher, S.H., and Miller, F.L. Mammary tumorigenesis in 7,12-dimethylbenzanthracene treated C57BL x DBA/2F-L mice. Cancer Res., 40: 368–373, 1980.
Sluyser, M., DeGoeij, C.C.J., and Evers, S.G. Outgrowth of grafts containing different ratios of hormone-dependent and independent mammary tumor cells. Cancer Letters, 13: 71–77, 1981.
Sluyser, M., DeGoiej, C.C.J., and Evers, S.G. Combined endocrine therapy and chemotherapy of mouse mammary tumors. Europ. J. Cancer, 17: 155–159, 1981.
Briand, P., Thorpe, S.M., and Daehnfeldt, J.L. Effect of prolactin and bromocriptine on growth of transplanted hormone-dependent mouse mammary tumours. Br. J. Cancer, 35: 816–821, 1977.
Matsuzawa, A. Progesterone effect on tumor growth and development.In: B.S. Leung (ed.), Hormonal Regulation of Mammary Tumors, Vol. 1, pp. 183–215. Montreal: Eden Press Inc., 1982.
Matsumoto, K., Sato, B., and Kitamura, Y. Roles of androgen and its receptors in mouse mammary tumor. In: B.S. Leung (ed.), Hormonal Regulation of Mammary Tumors, Vol. 1, pp. 216–244. Montreal: Eden Press Inc., 1982.
Matsumoto, A., Yamamoto, T., and Mizuno, Y. An ovary-dependent mouse mammary tumor induced by urethan. Gann, 68: 523–524, 1977.
Watson, C., Medina, D., and Clark, J.H. Estrogen receptor characterization in a transplantable mouse mammary tumor. Cancer Res., 37: 3344–3348, 1977.
Watson, C.S., Medina, D., and Clark, J.H. Characterization and estrogen stimulation of cytoplasmic progesterone receptor in the ovarian-dependent MXT-3590 mammary tumor line. Cancer Res., 39: 4098–4104, 1979.
Braunschweiger, P.G., and Schiffer, L.M. Antiproliferative effects of corticosteroids in C3H/HeJ mammary tumors and implications for sequential combination chemotherapy. Cancer Res., 41: 3324– 3330, 1981.
Medina, D. Mammary tumorigenesis in chemical carcinogen-treated mice. VI. Tumor-producing capabilities of mammary dysplasias in BALB/cCrgl mice. J. Natl. Cancer Inst., 57: 1185–1189, 1976.
Medina, D. Tumor formation in preneoplastic mammary nodule lines in mice treated with nafoxidine, testosterone, and 2-bromo-α- ergocryptine. J. Natl. Cancer Inst., 58: 1107–1110, 1977.
Medina, D. Serial transplantation of chemical carcinogen-induced mouse mammary ductal dysplasias. J. Natl. Cancer Inst., 62: 397–405, 1979.
Aidells, B.D., and Daniel, C.W. Hormone-dependent mammary tumors in strain GR/A mice. I. Alteration between ductal and tumorous phases of growth during serial transplantation. J. Natl. Cancer Inst., 52: 1855– 1863, 1974.
Aidells, B.D., and Daniel, C.W. Hormone-dependent mammary tumors in GR/A mice. III. Effectiveness of supplementary hormone treatments in inducing tumorous phase growth. J. Natl. Cancer Inst., 57: 527–537 1976.
Dux, A., and Muhlbock, 0. Enhancement by hypophyseal hormones of the malignant transformation of transplanted hyperplastic nodules of the mouse mammary gland. Europ. J. Cancer, 5: 191–194, 1969.
Noble, R.L., and Cutts, J.H. Mammary tumors of the rat: a review. Cancer Res., 19: 1125–1139, 1959.
Welsch, C.W., Jenkins, T.W., and Meites, J. Increased incidence of mammary tumors in the female rat grafted with multiple pituitaries. Cancer Res., 30: 1024–1029, 1970.
Durbin, P.W., Williams, M.H., Jeung, N., and Arnold, J.S. Development of spontaneous mammary tumors over the life-span of the female Charles River (Sprague-Dawley) rat; the influence of ovariectomy, thyroidectomy, and adrenalectomy-ovariectomy. Cancer Res., 26: 400–411, 1966.
Moon, H.D., Simpson, M.E., Li, C.H., and Evans, H.M. Neoplasms in rats treated with pituitary growth hormone. V. Absence of neoplasms in hypophysectomized rats. Cancer Res., 11: 535–539, 1951.
Cutts, J.H., and Noble, R.L. Estrone-induced mammary tumors in the rat. I. Induction and behavior of tumors. Cancer Res., 24: 1116– 1123, 1964.
Cutts, J.H. Estrogen-induced breast cancer in the rat.In: Proceedings of the Sixth Canadian Cancer Research Conf., Honey Harbour, Ontario, pp. 50–68. New York: Pergamon Press Inc., 1965.
Cutts, J.H. Estrone-induced mammary tumors in the rat. II. Effect of alterations in the hormonal environment on tumor induction, behavior, and growth. Cancer Res., 24: 1124–1130, 1964.
Welsch, C.W., Nagasawa, H., and Meites, J. Increased incidence of spontaneous mammary tumors in female rats with induced hypothalamic lesions. Cancer Res., 30: 2310–2313, 1970.
Geschickter, C.F., and Byrnes, E.W. Factors influencing the development and time of appearance of mammary cancer in the rat in response to estrogen. Arch. Pathol., 33: 334–356, 1942.
Quadri, S.K., and Meites, J. Regression of spontaneous mammary tumors in rats by ergot drugs. Proc. Soc. Exptl. Biol. Med., 138: 999–1001, 1971.
Welsch, C.W. Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res., 45: 3415–3443, 1985.
Welsch, C.W. Prolactin and murine mammary tumorigenesis: a review. Cancer Res., 37: 951– 963, 1977.
Welsch, C.W., Brown, C.K., Goodrich-Smith, M., Chiusano, J., and Moon, R.C. Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea- induced mammary tumorigenesis in female Sprague-Dawley rats. Cancer Res., 40: 3095– 3098, 1980.
Rose, D.P., and Noonan, J.J. Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea. Cancer Res., 42: 35–38, 1982.
Arafah, B.M., Finegan, H.M., Roe, J., Manni, A., and Pearson, O.H. Hormone dependence in N-nitrosomethylurea-induced rat mammary tumors. Endocrinology, 111: 584–588, 1982.
Rose, D.P., and Noonan, J.J. Hormone dependence of rat mammary tumors induced by N-nitrosomethylurea. Europ. J. Cancer Clin. Oncol., 17: 1357–1358, 1981.
Nagasawa, H., and Yanai, R. Effects of prolactin or growth hormone on growth of carcinogen-induced mammary tumors of adreno-ovariectomized rats. Int. J. Cancer, 6: 488–495, 1970.
King, D.T., and Kennedy, B.J. Combination of cyclophosphamide and estrogen therapy in DMBA-induced rat mammary cancer. Cancer, 28: 1202–1210, 1971.
Sterental, A., Dominquez, J.M., Weisman, C., and Pearson, O.H. Pituitary role in the estrogen dependency of experimental mammary cancer. Cancer Res., 23: 481–484, 1963.
Jabara, A.G., Toyne, P.H., and Harcourt, A.G. Effects of time and duration of progesterone administration on mammary tumors induced by 7,12-dimethylbenzanthracene is Sprague-Dawley rats. Br. J. Cancer, 27: 63–71, 1973.
Asselin, J., Kelly, P.A., Caron, M.G., and Labrie, F. Control of hormone receptor levels and growth of 7,12-dimethylbenzanthracene-induced mammary tumors by estrogens, progesterone and prolactin. Endocrinology, 101: 666– 671, 1977.
Grubbs, C.J., Peckham, J.C., and McDonough, K.D. Effect of ovarian hormones on the induction of 1-methyl-1-nitrosourea-induced mammary cancer. Carcinogenesis, 4: 495–497, 1983.
Aylsworth, C.F., Sylvester, P.W., Leung, F.C., andMeites, J. Inhibition of mammary tumor growth by dexamethasone in rats in the presence of high serum prolactin levels. Cancer Res., 40: 1863–1866, 1980.
Heuson, J.C., Legros, N., and Heimann, R. Influence of insulin administration on growth of the 7,12-dimethylbenzanthracene-induced mammary carcinoma in intact, oophorectomized, and hypophysectomized rats. Cancer Res., 32: 233–238, 1972.
Goodman, A.D., Hoekstra, S.J., and Marsh, P.S. Effects of hypothyroidism on the induction and growth of mammary cancer induced by 7,12-dimethylbenzanthracene in the rat. Cancer Res., 40: 2336–2342, 1980.
Armuth, V., and Berenblum, I. Promotion of mammary carcinogenesis and leukemogenic action by phorbol in virgin female Wistar rats. Cancer Res., 34: 2704–2707, 1974.
Shellabarger, C.J., Holtzman, S., and Stone, J.P. Apparent rat strain-related sensitivity to phorbol promotion of mammary carcinogenesis. Cancer Res., 39: 3345–3348, 1979.
Shellabarger, C.J. Pituitary and steroid hormones in radiation-induced mammary tumors.In: M.C. Pike, P.K. Siiteri, C.W. Welsch (eds.), Banbury Report #8, Hormones and Breast Cancer, pp. 339–351. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1981.
Takizawa, S., Naito, Y., Watanabe, H., and Hirose, F. Effect of ovariectomy on x-ray carcinogenesis in rats. Gann, 69: 353–360, 1978.
Welsch, C.W., Goodrich-Smith, M., Brown, C.K., Miglorie, N., and Clifton, K.H. Effect of an estrogen antagonist (tamoxifen) on the initiation and progression of γ-irradiation-induced mammary tumors in female Sprague-Dawley rats. Europ. J. Cancer Clin. Oncol., 17: 1255–1258, 1981.
Goodrich-Smith, M., Brown, C.K., and Welsch, C.W. Comparative effects of prolactin suppression and estrogen antagonism on the genesis of γ-irradiation induced mammary tumors in female Sprague-Dawley rats. The Physiologist, 23: 133, 1980.
Holtzman, S., Stone, J.P., and Shellabarger, C.J. Synergism of estrogens and x-rays in mammary carcinogenesis in female ACI rats. J. Natl. Cancer Inst., 67: 455– 59, 1981.
Ito, A., Naito, M., Watanabe, H., and Yokoro, K. Prolactin and aging: x-irradiated and estrogen-induced rat mammary tumorigenesis, J. Natl. Cancer Inst., 73: 123–126, 1984.
Clifton, K.H., and Crowley, J.J. Effects of radiation type and dose and the role of glucocorticoids, gonadectomy, and thyroidectomy in mammary tumor induction in mammotrophin-secreting pituitary grafted rats. Can Res., 38: 1507–1513, 1978.
Segaloff, A. Inhibition by progesterone of radiation-estrogen-induced mammary cancer in the rat. Cancer Res., 33: 1136–1137, 1973.
Kim, U., and Depowski, M.J. Progression from hormone dependence to autonomy in mammary tumors as in vivo manifestation of sequential clonal selection. Cancer Res., 35 2068–2077, 1975.
Kim, U., Furth, J., and Clifton, K.H. Relation of mammary tumors to mammotropes. III. Hormone responsiveness of transplanted mammary tumors. Proc. Soc. Exptl. Biol. Med., 103: 646–650, 1960.
MacLeod, R.M., Allen, M.S., and Hollander, V.P. Hormonal requirements for the growth of mammary adenocarcinoma (MTW9) in rats. Endocrinology, 75: 249–258, 1964.
Diamond, E.J., Koprak, S., and Hollander, V.P. Effect of high-dose progesterone on growth of rat mammary carcinoma. Cancer Res., 40: 1091–1096, 1980.
Sirbasku, D.A. Hormone-responsive growthin vivoof a tissue culture cell line established from the MT-W9A rat mammary tumor. Cancer Res., 38: 1154–1165, 1978.
Segaloff, A. Hormones and breast cancer. Rec. Prog. Hormone Res., 22: 351–379, 1966.
Bogden, A.E., Taylor, D.J., Kuo, E.Y.H., Manson, M.M., and Sperapoulos,A. The effect of perphenazine-induced serum prolactin response on estrogen-primed mammary tumor-host systems, 13762 and R-35 mammary adenocarcinomas. Cancer Res., 34: 3018–3025, 1974.
Harada, Y. Pituitary role in the growth of metastasizing MRMT-1 mammary carcinoma in rats. Cancer Res., 36: 18–22, 1976.
King, M.M., Magarian, R.A., Terao, J., and Brueggemann, G.L. Effects of nonsteroidal antiestrogens, analog II and tamoxifen, on a metastatic transplantable rat mammary tumor. J. Natl. Cancer Inst., 74: 447– 451, 1985.
Sonnenschein, C., Ucci, A.A., and Soto, A.M. Age-dependent growth inhibition of estrogen-sensitive rat mammary tumors. Probable role of alpha-fetoprotein. J. Natl. Cancer Inst., 64: 1141–1146, 1980.
Hilf, R., Freeman, J.J., Inge, M., and Borman, A. Characterization of a transplantable lactating mammary tumor: endocrinological, morphological and biochemical aspects. Cancer Res., 24: 812–814, 1964.
Cohen, N.D., and Hilf, R. Influence of insulin on estrogen-induced responses in the R3230AC mammary carcinoma. Cancer Res., 35: 560–567, 1975.
Noble, R.L. Hormonal control of growth and progression in tumors of Nb rats and a theory of action. Cancer Res., 37: 82–94, 1977.
Horn, T.M., and Kano-Sueoka, T. Effects of hormones on growth andα-lactalbumin activity in the transplantable rat mammary tumor MCCLX. Can Res., 39: 5028–5035, 1979.
Pantelouris, E.M. Absence of thymus in a mouse mutant. Nature, 217: 370–371, 1968.
Ryaard, J., and Povlsen, C.0. Heterotransplantation of a human malignant tumour to “nude” mice. Acta Pathol. Microbiol. Scand., 77: 758–760, 1969.
Daniel, C.W., Shannon, J.M., and Cunha, g.R. Transplanted mammary epithelium grows in association with host stroma: aging of serially transplanted mammary gland is intrinsic to epithelial cells. Mech. Aging Develop., 23: 259–264, 1983.
Welsch, C.W., O’Connor, D.H., Aylsworth, C.F., and Sheffield, L.G. Comparative acceptance rate of the xenogeneic normal and carcinomatous mammary gland upon transplantation to athymic nude mice. 14th Internatl. Cancer Congr., p. 67. Budapest, Hungary, 1986.
Welsch, C.W., McManus, M.J., DeHoog, J.V., Goodman, G.T., and Tucker, H.A. Hormone-induced growth and lactogenesis of grafts of bovine mammary gland maintained in the athymic “nude” mouse. Cancer Res., 39: 2046–2050, 1979.
Sheffield, L.G., and Welsch, C.W. Transplantation of bovine mammary epithelium subcutaneously and into the mammary gland free fat pads of athymic nude mice. J. Dairy Sci., in press.
McManus, M.J., and Welsch, C.W. DNA synthesis of benign human breast tumors in the untreated athymic “nude” mouse. Cancer, 45: 2160–2165, 1980.
McManus, M.J., and Welsch, C.W. Hormone-induced ductal DNA synthesis of human breast tissues maintained in the athymic nude mouse. Cancer Res., 41: 3300–3305, 1981.
McManus, M.J., and Welsch, C.W. The effect of estrogen, progesterone, thyroxine, and human placental lactogen on DNA synthesis of human breast ductal epithelium maintained in athymic nude mice. Cancer, 54: 1920– 1927, 1984.
Hillman, E.A., Valerio, M.G., Halter, S.A., Barrett-Boone, L.A., and Trump, B.F. Long-term explant culture of normal mammary epithelium. Cancer Res., 43: 245–257, 1983.
Sebesteny, A., Taylor-Papadimitriou, J., Ceriani, R., Mills, R., Schmitt, C., and Trevan, D. Primary human breast carcinomas transplantable in the nude mouse. J. Natl. Cancer Inst., 63: 1331–1337, 1979.
Fogh, J., Tiso, J., Orfeo, T., Sharkey, F.E., Daniels, W.P., and Fogh, J.M. Thirty-four lines of six human tumor categories established in nude mice. J. Natl. Cancer Inst., 64: 745– 751, 1980.
Engel, L.W., and Young, N.A. Human breast carcinoma cells in continuous culture: a review. Cancer Res., 38: 4327–4339, 1978.
Shafie, S.M., and Grantham, F.H. Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. J. Natl. Cancer Inst., 67: 51–56, 1981.
Welsch, C.W., Swim, E.L., McManus, M.J., White, A.C., and McGrath, C.M. Estrogen induced growth of human breast cancer cells (MCF-7) in athymic nude mice is enhanced by secretions from a transplantable pituitary tumor. Cancer Lett., 14: 309–316, 1981.
Osborne, C.K., Hobbs, K., and Clark, G.M. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res., 45: 584–590, 1985.
Leung, C.K.H., and Shiu, R.P.C. Required presence of both estrogen and pituitary factors for the growth of human breast cancer cells in athymic nude mice. Cancer Res., 41: 546–551, 1981.
Hirohashi, S., Shimosato, Y., Kameya, T., Nagai, K., and Tsunematsu, R. Hormone dependency of a serially transplantable human breast cancer (Br-10) in nude mice. Cancer Res., 37: 3184–3189, 1977.
Rudland, P.S., Gusterson, B.A., Hughes, C.M., Osmirod, E.J., and Warburton, M.J. Two forms of tumors in nude mice generated by a neoplastic rat mammary stem cell line. Cancer Res., 42: 5196–5208, 1982.
Bogden, A.E., Kelton, D.E., Cobb, W.R., Gulkin, T.A., and Johnson, R.K. Effect of serial passage in nude athymic mice on the growth characteristics and chemotherapy responsiveness of 13762 and R3230AC mammary tumor xenografts. Cancer Res., 38: 59–64, 1978.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Welsch, C.W. (1987). Rodent Models To ExamineIn Vivo Hormonal Regulation of Mammary Gland Tumorigenesis. In: Medina, D., Kidwell, W., Heppner, G., Anderson, E. (eds) Cellular and Molecular Biology of Mammary Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0943-7_10
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0943-7_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-42761-9
Online ISBN: 978-1-4613-0943-7
eBook Packages: Springer Book Archive